Results of research of brain-derived neurotrophic factor level (BDNF) in the vitreous body of patients with proliferative diabetic retinopathy

Introduction. Progression of the optic nerve neuropathy of diabetic genesis is currently associated with the neurotrophic factors dysfunction, in particular, brain-derived neurotrophic factor (BDNF), since it has a pronounced neuroprotective properties and plays an important role in retinal ganglion...

Full description

Bibliographic Details
Published in:	Journal of Ophthalmology
Main Authors:	A.A. Putienko, Elhadj Emhamed Ali, E.V. Kovaleva
Format:	Article
Language:	English
Published:	Ukrainian Society of Ophthalmologists 2016-02-01
Subjects:	proliferative diabetic retinopathy neurotrophic factor vitreous body
Online Access:	https://www.ozhurnal.com/en/archive/2016/1/7-fulltext

Similar Items

Outcomes of aflibercept for post-vitrectomy vitreous hemorrhage in patients with proliferative diabetic retinopathy
by: O. O. Putienko, et al.
Published: (2021-06-01)

Lipidomic analysis of vitreous humor derived from patients with proliferative diabetic retinopathy
by: Jiawei Wang, et al.
Published: (2025-10-01)

CLINICAL CHARACTERISTICS OF PROLIFERATIVE DIABETIC RETINOPATHY (PDR) PATIENTS WITH VITREOUS HEMORRHAGE AT CIPTO MANGUNKUSUMO HOSPITAL
by: Reyno Satria Ali, et al.
Published: (2023-02-01)

Findings of a study of pigment epithelium-derived factor (PEDF) levels in vitreous samples from patients with proliferative diabetic retinopathy
by: A.A. Putienko, et al.
Published: (2016-06-01)

Intravitreal Bevacizumab (Avastin) in Treatment of Vitreous Hemorrhage due to Proliferative Diabetic Retinopathy
by: Attaullah Shah Bukhari, et al.
Published: (2018-06-01)

Characterization of Vitreous Microbiota Dysbiosis Associated with Proliferative Diabetic Retinopathy
by: Song F, et al.
Published: (2025-07-01)

The multifaceted role of vitreous hyalocytes: Orchestrating inflammation, angiomodulation and erythrophagocytosis in proliferative diabetic retinopathy
by: Stefaniya K. Boneva, et al.
Published: (2024-11-01)

Comprehensive assessment of growth factors, inflammatory mediators, and cytokines in vitreous from patients with proliferative diabetic retinopathy
by: Qiao-Yun Gong, et al.
Published: (2022-11-01)

Intravitreal conbercept injection with panretinal photocoagulation for high-risk proliferative diabetic retinopathy with vitreous hemorrhage
by: Yao Xu, et al.
Published: (2024-06-01)

Late postoperative vitreous cavity hemorrhage after vitrectomy for proliferative diabetic retinopathy—observation versus intervention
by: Anand S Brar, et al.
Published: (2024-01-01)

Proteomic study of vitreous in proliferative diabetic retinopathy patients after treatment with aflibercept: a quantitative analysis based on 4D label-free technique
by: Ting-Ting Feng, et al.
Published: (2024-04-01)

Meta-Analysis of risk factors and clinical significance for postoperative vitreous hemorrhage in proliferative diabetic retinopathy
by: Cheng Tang, et al.
Published: (2025-08-01)

Liquid Biopsy for Proliferative Diabetic Retinopathy: Single-Cell Transcriptomics of Human Vitreous Reveals Inflammatory T-Cell Signature
by: Rachana Haliyur, MD, PhD, et al.
Published: (2024-11-01)

Searching for Biomarkers in Proliferative Diabetic Retinopathy: Amphiregulin and Progranulin
by: Burak BILGIN, et al.
Published: (2022-12-01)

Hypertension as an Unusual Cause of Proliferative Retinopathy: Case Report and Literature Review
by: Rami Hasan Saleem Abu Sbeit, et al.
Published: (2021-07-01)

Assessment of the degree of diabetic neuropathy of the optic nerve following intravitreal interventions in proliferative diabetic retinopathy
by: Elhage Emhamed Ali, et al.
Published: (2016-04-01)

Factors related to postoperative vitreous hemorrhage after small-gauge vitrectomy in proliferative diabetic retinopathy patients
by: Meng Zhao, et al.
Published: (2023-05-01)

Correlation Between Vitreous Advanced Glycation End Products, and D-dimer with Blood HbA1c Levels in Proliferative Diabetic Retinopathy
by: Tonny Loho, et al.
Published: (2018-06-01)

Correlation Between Vitreous Advanced Glycation End Products, and D-dimer with Blood HbA1c Levels in Proliferative Diabetic Retinopathy
by: Tonny Loho, et al.
Published: (2018-06-01)

The Efficacy of Intravitreal Bevacizumab in Vitreous Hemorrhage of Diabetic Subjects
by: Cengiz Alagöz, et al.
Published: (2016-10-01)

Causes of vitreous haemorrhage in a tertiary hospital in southern Nigeria
by: Otabor-Olubor OJ, et al.
Published: (2021-01-01)

Screening Blood and Vitreous for Biomarkers Associated with Proliferative Diabetic Retinopathy
by: Stephen Richard, et al.
Published: (2025-05-01)

Study of Etiology of Vitreous Hemorrhage in Adult Patients Attending Tertiary Care Eye Center in Western India
by: Neha Desai, et al.
Published: (2023-04-01)

Quantitative proteomics analysis of vitreous body from type 2 diabetic patients with proliferative diabetic retinopathy
by: Jianqing Li, et al.
Published: (2018-06-01)

Anatomic and Topographic Vitreous and Vitreoretinal Interface Features in Proliferative Diabetic Vitreoretinopathy
by: N. M. Kislitsyna, et al.
Published: (2020-06-01)

Analysis of Risk Factors for Revitrectomy in Eyes with Diabetic Vitreous Hemorrhage
by: Guo H, et al.
Published: (2023-09-01)

Analysis of Risk Factors for Revitrectomy in Eyes with Diabetic Vitreous Hemorrhage [Corrigendum]
by: Guo H, et al.
Published: (2023-10-01)

Reoperation following vitrectomy for diabetic vitreous hemorrhage with versus without preoperative intravitreal bevacizumab
by: Xuting Hu, et al.
Published: (2019-09-01)

Vitreous VEGF levels among patients with proliferative diabetic retinopathy depending on the general clinical status and ocular statusVitreous VEGF levels among patients with proliferative diabetic retinopathy depending on the general clinical status and ocular status
by: Vira S. Ponomarchuk, et al.
Published: (2021-08-01)

Cytokine Levels in Human Vitreous in Proliferative Diabetic Retinopathy
by: Dean F. Loporchio, et al.
Published: (2021-04-01)

miR-124, miR-126-3p, and miR-200b: Potential therapeutic targets for VEGF-mediated complications in proliferative diabetic retinopathy
by: Irfan Akaray, et al.
Published: (2025-06-01)

Aberrant lncRNA expression in patients with proliferative diabetic retinopathy: preliminary results from a single-center observational study
by: Lan Zeng, et al.
Published: (2023-03-01)

Regression of Neovascularization after Panretinal Photocoagulation Combined with Anti-VEGF Injection for Proliferative Diabetic Retinopathy—A Review
by: Maciej Gawęcki, et al.
Published: (2023-12-01)

Managing proliferative diabetic retinopathy in a patient with vitreous hemorrhage: a case report
by: O. B. Koshchynets, et al.
Published: (2022-06-01)

Peripheral Retinal Neovascularization with Vitreous Hemorrhage in HIV Retinopathy
by: Kim Jiramongkolchai, et al.
Published: (2017-06-01)

Antioxidant Status in the Vitreous of Eyes with Rhegmatogenous Retinal Detachment with and without Proliferative Vitreoretinopathy, Macular Hole and Epiretinal Membrane
by: Agata Pietras-Baczewska, et al.
Published: (2021-05-01)

Exploring extracellular vesicles metrics in diabetic retinopathy vitreous, aqueous, and plasma
by: Kleber S. Ribeiro, et al.
Published: (2025-05-01)

WTH FACTORS IN THE PATHOGENESIS OF PROLIFERATIVE DIABETIC RETINOPATHY
by: A. N. Trunov, et al.
Published: (2017-04-01)

Bilateral proliferative retinopathy in B-cell acute lymphoblastic leukemia
by: Devesh Kumawat, et al.
Published: (2018-01-01)

Exosomal miRNA Profiling in Vitreous Humor in Proliferative Diabetic Retinopathy
by: Agnieszka Kot, et al.
Published: (2022-12-01)